Mangoceuticals Inc. (MGRX)
NASDAQ: MGRX
· Real-Time Price · USD
1.58
-0.12 (-7.06%)
At close: Aug 14, 2025, 3:59 PM
1.69
6.96%
Pre-market: Aug 15, 2025, 08:00 AM EDT
Company Description
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform.
It offers erectile dysfunction products under the Mango brand name.
The company sells its products through online website mangorx.com.
Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas.
Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
Mangoceuticals Inc.
| Country | United States |
| IPO Date | Mar 21, 2023 |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Employees | 3 |
| CEO | Jacob D. Cohen |
Contact Details
Address: 15110 North Dallas Parkway Dallas, Texas United States | |
| Website | https://www.mangorx.com |
Stock Details
| Ticker Symbol | MGRX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001938046 |
| CUSIP Number | 56270V106 |
| ISIN Number | US56270V1061 |
| Employer ID | 87-3841292 |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| Jacob D. Cohen | Co-Founder, Chief Executive Officer & Chairman |
| Amanda Elizabeth Hammer | Chief Operating Officer |
| Eugene M. Johnston | Chief Financial Officer |
| Antonios Isaac | President & Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 14, 2025 | 10-Q | Quarterly Report |
| Aug 04, 2025 | 8-K | Current Report |
| Jul 23, 2025 | 8-K | Current Report |
| Jul 10, 2025 | 8-K | Current Report |
| Jul 03, 2025 | 8-K | Current Report |
| Jun 13, 2025 | S-3 | Filing |
| Jun 10, 2025 | 8-K | Current Report |
| May 30, 2025 | S-1 | Filing |
| May 30, 2025 | 8-K | Current Report |
| May 23, 2025 | 8-K | Current Report |